ENSC
Ensysce BiosciencesยทNASDAQ
--
--(--)
--
--(--)
ENSC Profile
Ensysce Biosciences, Inc.
A clinical stage pharmaceutical company seeking to develop innovative solutions for severe pain relief while reducing the fear of and the potential for misuse, abuse, and overdose
7946 Ivanhoe Avenue, Suite 201, La Jolla, California 92037
--
Ensysce Biosciences, Inc., was incorporated in Delaware in April 2003. The company is a clinical-stage biotechnology company that leverages its proprietary technology platform to develop safer prescription drugs. Using its trypsin-activated abuse protection and multidrug abuse resistance platform, the company is developing a new class of powerful, tamper-proof opioids that can prevent drug abuse and overdose. Ensysce's products are expected to provide a safer option to treat severe pain and help prevent deaths from opioid abuse, thereby reducing human and economic costs.
